Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02508298 · ClinicalTrials.gov registry record · NA
Surrogate Markers of Portal Pressure
A NA study, sponsored by VA Connecticut Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT02508298: Completed NA study, sponsored by VA Connecticut Healthcare System.
NCT02508298 is a NA study that has completed, run by VA Connecticut Healthcare System. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02508298, a NA study, has completed, sponsored by VA Connecticut Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This is a prospective longitudinal study that will evaluate if changes (pre and post therapy) in indocyanine green (ICG) retention test and liver stiff ness (LS) and spleen stiffness (SS) as measured by acoustic radiofrequency impulse (ARFI) correlate with changes in portal pressure as determined by the hepatic vein pressure gradient (HVPG) in patients with compensated hepatitis C virus (HCV) cirrhosis undergoing antiviral therapy.
Interventions
- PROCEDURE HVPG
- DRUG Indocyanine Green Retention test
- DEVICE Liver stiffness measurement
- DEVICE Spleen stiffness measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2014-04 |
| Est. Completion | 2019-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02508298
The ClinicalTrials.gov registry entry for NCT02508298 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Connecticut Healthcare System, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which HVPG is the first listed.
NCT02508298 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02508298 about?
NCT02508298 is a clinical study titled "Surrogate Markers of Portal Pressure". This is a prospective longitudinal study that will evaluate if changes (pre and post therapy) in indocyanine green (ICG) retention test and liver stiff ness (LS) and spleen stiffness (SS) as measured by acoustic radiofrequency impulse (ARFI) correlate with changes in portal pressure as determined by...
What is the current status of trial NCT02508298?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2014-04. Estimated completion is 2019-07.
What interventions are being tested in trial NCT02508298?
The interventions under investigation include: HVPG (PROCEDURE), Indocyanine Green Retention test (DRUG), Liver stiffness measurement (DEVICE), Spleen stiffness measurement (DEVICE).
Who is sponsoring clinical trial NCT02508298?
This trial is sponsored by VA Connecticut Healthcare System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.